Seizert Capital Partners, LLC Vertex Pharmaceuticals Inc Transaction History

Seizert Capital Partners, LLC

  • $2.14 Billion
  • Q4 2024

A detailed history of Seizert Capital Partners, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Seizert Capital Partners, LLC holds 4,165 shares of VRTX stock, worth $2 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,165
Previous 10,711 61.11%
Holding current value
$2 Million
Previous $4.98 Million 66.33%
% of portfolio
0.08%
Previous 0.23%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
$396.64 - $516.74 $2.6 Million - $3.38 Million
-6,546 Reduced 61.11%
4,165 $1.68 Million
Q3 2024

Nov 06, 2024
BUY
$460.0 - $505.78 $9,200 - $10,115
20 Added 0.19%
10,711 $4.98 Million
Q2 2024

Aug 07, 2024
SELL
$392.81 - $485.53 $575,859 - $711,786
-1,466 Reduced 12.06%
10,691 $5.01 Million
Q1 2024

May 01, 2024
SELL
$407.69 - $446.08 $169,191 - $185,123
-415 Reduced 3.3%
12,157 $5.08 Million
Q4 2023

Feb 07, 2024
SELL
$343.0 - $410.68 $1.65 Million - $1.98 Million
-4,823 Reduced 27.73%
12,572 $5.12 Million
Q3 2023

Nov 06, 2023
SELL
$338.18 - $362.46 $113,290 - $121,424
-335 Reduced 1.89%
17,395 $6.05 Million
Q2 2023

Jul 27, 2023
SELL
$314.42 - $351.91 $3.48 Million - $3.9 Million
-11,069 Reduced 38.44%
17,730 $6.24 Million
Q1 2023

May 09, 2023
SELL
$283.23 - $323.1 $2.15 Million - $2.45 Million
-7,582 Reduced 20.84%
28,799 $9.07 Million
Q4 2022

Jan 30, 2023
SELL
$285.76 - $321.48 $982,442 - $1.11 Million
-3,438 Reduced 8.63%
36,381 $10.5 Million
Q3 2022

Nov 02, 2022
SELL
$273.83 - $305.53 $45,181 - $50,412
-165 Reduced 0.41%
39,819 $11.5 Million
Q2 2022

Aug 04, 2022
SELL
$234.96 - $292.55 $22,086 - $27,499
-94 Reduced 0.23%
39,984 $11.3 Million
Q1 2022

May 03, 2022
BUY
$221.42 - $260.97 $327,701 - $386,235
1,480 Added 3.83%
40,078 $10.5 Million
Q4 2021

Feb 08, 2022
BUY
$177.01 - $223.45 $644,316 - $813,358
3,640 Added 10.41%
38,598 $8.48 Million
Q3 2021

Nov 03, 2021
BUY
$181.39 - $202.99 $181 - $202
1 Added 0.0%
34,958 $6.34 Million
Q2 2021

Aug 05, 2021
BUY
$187.49 - $221.1 $205,864 - $242,767
1,098 Added 3.24%
34,957 $7.05 Million
Q1 2021

May 05, 2021
BUY
$207.02 - $241.31 $7.01 Million - $8.17 Million
33,859 New
33,859 $7.28 Million

Others Institutions Holding VRTX

# of Institutions
1,715
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $124B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Seizert Capital Partners, LLC Portfolio

Follow Seizert Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seizert Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email